Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
Programmed cell death protein-1 (PD-1) checkpoint immunotherapy efficacy remains unpredictable in glioblastoma (GBM) patients due to the genetic heterogeneity and immunosuppressive tumor microenvironments. Here, we report a microfluidics-based, patient-specific ‘GBM-on-a-Chip’ microphysiological sys...
Main Authors: | Xin Cui, Chao Ma, Varshini Vasudevaraja, Jonathan Serrano, Jie Tong, Yansong Peng, Michael Delorenzo, Guomiao Shen, Joshua Frenster, Renee-Tyler Tan Morales, Weiyi Qian, Aristotelis Tsirigos, Andrew S Chi, Rajan Jain, Sylvia C Kurz, Erik P Sulman, Dimitris G Placantonakis, Matija Snuderl, Weiqiang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2020-09-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/52253 |
Similar Items
-
In vitro evidence for glioblastoma cell death in temperatures found in the penumbra of laser-ablated tumors
by: Joshua D. Frenster, et al.
Published: (2020-07-01) -
Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment
by: Ainhoa Hernández, et al.
Published: (2021-12-01) -
Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma
by: Weilun Fu, et al.
Published: (2020-05-01) -
Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping
by: James F. Lyon, et al.
Published: (2021-06-01) -
Pitfalls in the diagnosis of glioblastoma
by: Bica Dorin, et al.
Published: (2023-03-01)